Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prediction of survival with intensive chemotherapy in acute myeloid leukemia.

American journal of hematology - 1 Jul 2022

Sasaki Koji, Ravandi Farhad, Kadia Tapan, DiNardo Courtney, Borthakur Gautam, Short Nicholas, Jain Nitin, Daver Naval, Jabbour Elias, Garcia-Manero Guillermo, Khoury Joseph, Konoplev Sergej, Loghavi Sanam, Patel Keyur, Montalban-Bravo Guillermo, Masarova Lucia, Konopleva Marina, Kantarjian Hagop

Abstract excerpt

Progress with intensive chemotherapy and supportive care measures has improved survival in newly diagnosed acute myeloid leukemia (AML). Predicting outcome helps in treatment decision making. We analyzed survival as the treatment endpoint in 3728 patients with newly diagnosed AML treated with intensive chemotherapy from 1980 to 2021. We divided the total study group (3:1 basis) into a training (n = 2790) and a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosome Aberrations
Share to Hematopoietic Stem Cell Transplantation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia, Myeloid, Acute

Share to Mutation

Share to Prognosis

Share to Remission Induction

Source

Identifiers

PMID: 35384048
DOI: 10.1002/ajh.26557

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prediction of survival with intensive chemotherapy in acute myeloid leukemia.PMID 35384048Read ↗

ELN 2017 classification significantly impacts the risk of early death in acute myeloid leukemia patients receiving intensive induction chemotherapy.Semantic proximity Read ↗

Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemia.Semantic proximity Read ↗

Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia.Semantic proximity Read ↗

Beat-AML 2024 ELN-refined risk stratification for older adults with newly diagnosed AML given lower-intensity therapy.Semantic proximity Read ↗

Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management.Semantic proximity Read ↗

[Analysis of risk factors for early death in NPM1-mutated acute myeloid leukemia patients].Semantic proximity Read ↗

A scoring system for AML patients aged 70 years or older, eligible for intensive chemotherapy: a study based on a large European data set using the DATAML, SAL, and PETHEMA registries.Semantic proximity Read ↗

Classification of acute myeloid leukemia based on multi‐omics and prognosis prediction valueSemantic proximity Read ↗

Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study.Semantic proximity Read ↗

Personalized Survival Prediction of Patients With Acute Myeloblastic Leukemia Using Gene Expression ProfilingSemantic proximity Read ↗

The characteristics and prognostic analysis of therapy-related acute myeloid leukemia patients in China.Semantic proximity Read ↗

A precision medicine classification for treatment of acute myeloid leukemia in older patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.